Professor Andrew Tee
Projects as PI
- An all Wales collaborative project on Ferroptosis and Tuberous Sclerosis Complex (01/04/2023 - 31/03/2025)
- Analysis of novel therapies and survival mechanisms in TSC2 deficient cells (01/12/2015 - 30/11/2017)
- An investigation into the effects that CBD has in two TSC cell lines, alone and in combination with rapamycin (12/08/2018 - 30/09/2022)
- Cannabinoid therapy for Tuberous Sclerosis (01/08/2016 - 28/02/2017)
- Cannabinoid therapy on tuberous sclerosis complex cell lines (01/10/2015 - 31/12/2015)
Projects as Co-Investigator
- Cancer Genetics Biomedical Research Unit (31/03/2011 - 31/05/2015)
- Characterising the role of exosomes in Tuberous Sclerosis complex (01/10/2018 - 31/01/2022)
- Identification of the molecular defects associated with CDKL5 deficiency (01/08/2014 - 30/04/2016)
- Identification of the molecular defects in metabolic pathways associated with MECP2 deficiency (01/07/2013 - 30/06/2014)
- Structural analysis of the mTOR kinase domain by X-ray crystallography (01/10/2009 - 30/04/2013)